Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Glioma × binimetinib × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2 Thoracic 1 Sarcoma 1 Head & Neck 1 Dermatologic 1

Conditions

Gastrointestinal Stromal Tumors 3 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Astrocytoma 1

Interventions

Temozolomide 49 Bevacizumab 21 Radiotherapy 15 Irinotecan 14 Magnetic Resonance Spectroscopy 13 Erlotinib Hydrochloride 10 Carmustine 10 Carboplatin 8 Imatinib Mesylate 6 Filgrastim 6 Cyclophosphamide 6 Biopsy 6 sargramostim 5 X-Rays 5 Thalidomide 5 Phantoms, Imaging 5 O(6)-benzylguanine 5 Chemotherapy, Adjuvant 5 Topotecan 4 Surgical Procedures, Operative 4 Specimen Handling 4 Radiation 4 Peripheral Blood Stem Cell Transplantation 4 Nuclear Medicine Department, Hospital 4 vandetanib 3 temsirolimus 3 palbociclib 3 aldesleukin 3 Thiotepa 3 Sirolimus 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03973918 2024-10-31

BRAF

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated

5 enrolled 15 charts

Astrocytoma, Glioblastoma, Glioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡